'Medicaid best price' changes aimed at value-based gene therapy contracts: U.S. agency
Proposed changes to requirements that state-run Medicaid programs are given the best drug prices would clear the way for commercial health insurers to enter into "value-based" payment schemes, the U.S. Centers for Medicare & Medicaid Services said on Wednesday. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: Medicaid, changes, Services, Medicare, Centers, schemes, payment, "value-based", enter, insurers, health, commercial, clear, would, prices, given, programs, state-run, requirements, Proposed, agency, contracts, therapy, value-based, aimed, price', 'Medicaid